This page is part of the PanCareSurPass Project HL7 FHIR Implementation Guide (v0.1.0: QA Preview) based on FHIR R4. This is the current published version. For a full list of available versions, see the Directory of published versions
Official URL: http://hl7.eu/fhir/ig/pcsp/ValueSet/mcode-cancer-staging-system-vs | Version: 0.1.0 | |||
Active as of 2023-01-26 | Computable Name: CancerStagingSystemVS | |||
Copyright/Legal: This value set includes content from SNOMED CT, which is copyright © 2002+ International Health Terminology Standards Development Organisation (IHTSDO), and distributed by agreement between IHTSDO and HL7. Implementer use of SNOMED CT is not covered by this agreement |
System used for staging.
References
http://snomed.info/sct
where concept is-a 254292007 (Tumor staging)
This value set contains 140 concepts
Expansion based on SNOMED CT International edition 31-lug 2022
Code | System | Display |
254292007 | http://snomed.info/sct | Tumor staging |
13808002 | http://snomed.info/sct | WR stage 3 |
15972002 | http://snomed.info/sct | WR stage 2 |
42114005 | http://snomed.info/sct | WR stage 1 |
66470009 | http://snomed.info/sct | WR stage 5 |
74542008 | http://snomed.info/sct | WR stage 4 |
83200007 | http://snomed.info/sct | WR stage 6 |
106242004 | http://snomed.info/sct | Walter Reed staging of prostatic cancer |
106244003 | http://snomed.info/sct | FIGO staging of endometrial carcinoma |
106245002 | http://snomed.info/sct | FIGO staging of vulvar carcinoma |
106246001 | http://snomed.info/sct | FIGO staging of vulvar melanoma |
106247005 | http://snomed.info/sct | FIGO staging for epithelial tumor of ovary |
106250008 | http://snomed.info/sct | FIGO staging of cervical carcinoma |
106252000 | http://snomed.info/sct | Staging classification for lymphoma |
110375007 | http://snomed.info/sct | Overlapping tumor |
254360008 | http://snomed.info/sct | Dukes staging system |
254361007 | http://snomed.info/sct | Astler-Coller staging system |
254362000 | http://snomed.info/sct | Modified Astler-Coller staging system |
254363005 | http://snomed.info/sct | International neuroblastoma staging system |
254364004 | http://snomed.info/sct | NWTS - National Wilms' tumor study staging system |
254365003 | http://snomed.info/sct | Siopel liver staging system |
254366002 | http://snomed.info/sct | Stannard staging system for retinoblastoma |
254368001 | http://snomed.info/sct | United Kingdom children's cancer study group central nervous system tumor staging system |
254370005 | http://snomed.info/sct | St Jude's malignant histiocytosis tumor staging system |
254371009 | http://snomed.info/sct | St Jude's non-Hodgkin's lymphoma staging system |
254372002 | http://snomed.info/sct | Ann Arbor lymphoma staging system |
254373007 | http://snomed.info/sct | Ann Arbor Hodgkin's disease tumor staging system |
254374001 | http://snomed.info/sct | Ann Arbor non-Hodgkin's lymphoma tumor staging system |
254375000 | http://snomed.info/sct | Cotswolds Hodgkin's disease tumor staging system |
254376004 | http://snomed.info/sct | Testicular tumor staging systems |
254378003 | http://snomed.info/sct | Walter Reed testicular tumor staging system |
254379006 | http://snomed.info/sct | Indiana University testicular tumor staging system |
254380009 | http://snomed.info/sct | Marshall Modification of Jewett-Strong staging system for urinary bladder tumor |
254381008 | http://snomed.info/sct | American Urological Association staging system for prostate cancer |
254382001 | http://snomed.info/sct | Trophoblastic malignancy staging system |
254383006 | http://snomed.info/sct | FIGO staging of gynecological malignancy |
254384000 | http://snomed.info/sct | FIGO Vaginal tumor staging |
254385004 | http://snomed.info/sct | Federation internationale de gynecologie et d'obstetrique staging of corpus uteri malignancy |
254386003 | http://snomed.info/sct | Federation Internationale de gynecologie et d'obstetrique staging of ovarian malignancy |
258233007 | http://snomed.info/sct | Generic tumor staging descriptor (tumor staging) |
258234001 | http://snomed.info/sct | TNM tumor staging classifications |
258244004 | http://snomed.info/sct | G status |
258246002 | http://snomed.info/sct | L status |
258247006 | http://snomed.info/sct | V status |
258257007 | http://snomed.info/sct | Additional tumor staging descriptor (tumor staging) |
258258002 | http://snomed.info/sct | (f) |
258259005 | http://snomed.info/sct | is |
258260000 | http://snomed.info/sct | (d) |
258267002 | http://snomed.info/sct | Generic tumor risk status stages |
258268007 | http://snomed.info/sct | Low risk tumor |
258269004 | http://snomed.info/sct | Medium risk tumor |
258270003 | http://snomed.info/sct | High risk tumor |
258271004 | http://snomed.info/sct | Specific tumor staging descriptor (tumor staging) |
258272006 | http://snomed.info/sct | Liver tumor staging descriptor (tumor staging) |
258273001 | http://snomed.info/sct | Liver tumor size index |
258276009 | http://snomed.info/sct | Timing of liver tumor staging |
258279002 | http://snomed.info/sct | Lymphoma staging symptom status values |
258280004 | http://snomed.info/sct | Lymphomatous extranodal involvement status values |
258281000 | http://snomed.info/sct | S+ minimal |
258282007 | http://snomed.info/sct | S+ extensive |
258283002 | http://snomed.info/sct | Lymphomatous nodal involvement |
258284008 | http://snomed.info/sct | Stannards retinoblastoma stages |
258285009 | http://snomed.info/sct | Optic nerve tumor invasion status in retinoblastoma staging |
258286005 | http://snomed.info/sct | Choroidal tumor invasion status in retinoblastoma staging |
258292004 | http://snomed.info/sct | Lymph nodal tumor invasion status in retinoblastoma staging |
258293009 | http://snomed.info/sct | Brain tumor invasion status in retinoblastoma staging |
258301001 | http://snomed.info/sct | Langerhans cell histiocytosis stage (tumor staging) |
258302008 | http://snomed.info/sct | Number of organ systems involved with Langerhans cell histiocytosis |
258303003 | http://snomed.info/sct | Single system involvement |
258304009 | http://snomed.info/sct | Multisystem involvement |
258305005 | http://snomed.info/sct | Organ failure due to Langerhans cell histiocytosis |
258306006 | http://snomed.info/sct | Vital organ failure |
258307002 | http://snomed.info/sct | Non-vital organ failure |
258309004 | http://snomed.info/sct | Generic lymph node tumor invasion status stage (tumor staging) |
258310009 | http://snomed.info/sct | Neck node tumor involvement |
258311008 | http://snomed.info/sct | M+ |
258312001 | http://snomed.info/sct | Axillary lymph node level |
258313006 | http://snomed.info/sct | Level I |
258314000 | http://snomed.info/sct | Midaxilla |
258315004 | http://snomed.info/sct | Level III |
258316003 | http://snomed.info/sct | Retroperitoneal lymph node tumor invasion status |
258318002 | http://snomed.info/sct | Generic anatomical site tumor invasion status |
258319005 | http://snomed.info/sct | Lung involvement stages |
258320004 | http://snomed.info/sct | Lung stage L2 |
258321000 | http://snomed.info/sct | Lung stage L3 |
258322007 | http://snomed.info/sct | H+ |
258323002 | http://snomed.info/sct | Liver sectors |
258324008 | http://snomed.info/sct | Liver sector 1 |
258325009 | http://snomed.info/sct | Liver sector 2 |
258326005 | http://snomed.info/sct | Liver sector 3 |
258327001 | http://snomed.info/sct | Liver sector 4 |
258328006 | http://snomed.info/sct | Markers for liver tumor staging |
261731003 | http://snomed.info/sct | CNS metastases |
261789009 | http://snomed.info/sct | Extra CNS metastases |
261985008 | http://snomed.info/sct | No metastases |
277318003 | http://snomed.info/sct | (m) |
277645005 | http://snomed.info/sct | Additional TNM descriptors |
278241006 | http://snomed.info/sct | Node stage G1 |
278242004 | http://snomed.info/sct | Node stage G2 |
278247005 | http://snomed.info/sct | Lung stage L1 |
282402005 | http://snomed.info/sct | V - Hepatic vein marker |
282403000 | http://snomed.info/sct | P - Portal vein marker |
282404006 | http://snomed.info/sct | E - Extrahepatic marker |
282405007 | http://snomed.info/sct | M - Metastatic marker |
282436004 | http://snomed.info/sct | E - Extralymphatic organ involvement marker |
282437008 | http://snomed.info/sct | S - Splenic involvement marker |
385345007 | http://snomed.info/sct | Clark system for melanoma staging (tumor staging) |
385346008 | http://snomed.info/sct | Breslow system for melanoma staging (tumor staging) |
385359000 | http://snomed.info/sct | Modified Dukes staging system (tumor staging) |
417957003 | http://snomed.info/sct | Uveal metastasis (tumor staging) |
420417005 | http://snomed.info/sct | Liver tumor size index more than 0.05 (tumor staging) |
420483003 | http://snomed.info/sct | Abdominal lymph node tumor invasion status A (tumor staging) |
420533005 | http://snomed.info/sct | Choroidal invasion stage C1 in retinoblastoma (tumor staging) |
420728008 | http://snomed.info/sct | Timing of liver tumor staging at diagnosis (tumor staging) |
420841002 | http://snomed.info/sct | Choroidal invasion stage C0 in retinoblastoma (tumor staging) |
420889006 | http://snomed.info/sct | Liver tumor size index less than 0.05 (tumor staging) |
420969009 | http://snomed.info/sct | Lymphoma staging symptom status A (tumor staging) |
421074006 | http://snomed.info/sct | Central nervous system stage B3 in retinoblastoma (tumor staging) |
421174009 | http://snomed.info/sct | Choroidal invasion stage C2 in retinoblastoma (tumor staging) |
421188008 | http://snomed.info/sct | Tumor staging descriptor r (tumor staging) |
421211000 | http://snomed.info/sct | Lymphoma staging symptom status B (tumor staging) |
421294007 | http://snomed.info/sct | Timing of liver tumor staging pre-surgery (tumor staging) |
421426001 | http://snomed.info/sct | Tumor staging descriptor a (tumor staging) |
421432006 | http://snomed.info/sct | Choroidal invasion stage C3 in retinoblastoma (tumor staging) |
421655002 | http://snomed.info/sct | Optic nerve invasion stage N1 in retinoblastoma (tumor staging) |
421683000 | http://snomed.info/sct | Optic nerve invasion stage N0 in retinoblastoma (tumor staging) |
421745006 | http://snomed.info/sct | Choroidal invasion stage C4 in retinoblastoma (tumor staging) |
421755005 | http://snomed.info/sct | Tumor staging descriptor y (tumor staging) |
421824005 | http://snomed.info/sct | Tumor staging descriptor p (tumor staging) |
421838003 | http://snomed.info/sct | Optic nerve invasion stage N3 in retinoblastoma (tumor staging) |
421923000 | http://snomed.info/sct | Central nervous system stage B2 in retinoblastoma (tumor staging) |
422196000 | http://snomed.info/sct | Tumor staging descriptor D (tumor staging) |
422203007 | http://snomed.info/sct | Central nervous system stage B1 in retinoblastoma (tumor staging) |
443830009 | http://snomed.info/sct | American Joint Commission on Cancer, Cancer Staging Manual, 7th edition neoplasm staging system (tumor staging) |
444256004 | http://snomed.info/sct | American Joint Commission on Cancer, Cancer Staging Manual, 6th edition neoplasm staging system (tumor staging) |
897275008 | http://snomed.info/sct | American Joint Commission on Cancer, Cancer Staging Manual, 8th edition tumor staging system |
1149099005 | http://snomed.info/sct | Binet staging classification for chronic lymphocytic leukemia (tumor staging) |
1149131009 | http://snomed.info/sct | Rai staging system for chronic lymphocytic leukemia (tumor staging) |
1149164009 | http://snomed.info/sct | ACPS (Australian Clinico-pathological Staging) System for colorectal cancer |
1149295006 | http://snomed.info/sct | Malignant tumor staging (tumor staging) |
Explanation of the columns that may appear on this page:
Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
Code | The code (used as the code in the resource instance) |
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
Definition | An explanation of the meaning of the concept |
Comments | Additional notes about how to use the code |